This is a $3,111,212 Firm Fixed Price contract awarded by the U.S. Army Medical Command (MEDCOM) to Kericure Inc., a woman-owned small business, for the clinical validation of a portable, ruggedized antimicrobial wound dressing for the management of large surface area burns in prolonged field care and long-term care settings. The contract is part of the Small Business Innovation Research (SBIR) Program's Phase III, which focuses on the demonstration and delivery of technologies that have...
The Department of the Army Medical Command awarded Keranetics Inc., doing business as Keranetics, a $699,139.77 firm fixed price contract to support research and development efforts under Phase II of the Small Business Innovation Research program. The contract aims to advance Keranetics' KeraStat(R) gel technology to prevent scar contracture after burn injuries, as proposed in their submission titled "KeraStat(R) Gel to Prevent Scar Contracture After Burn Injuries." The prime...
This federal contract award is for a Phase I Small Business Innovation Research (SBIR) effort by the Department of the Army Medical Command. The contract, valued at $167,500.00, was awarded to Critical Innovations LLC, a for-profit limited liability company focused on medical research and development. The contract is for the development of "Succor Combat Foam for Advanced Wound Care of Traumatized Tissue," which supports the Army's medical research and development efforts. As a Phase I...
This is a $999,998.87 Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Health Agency (DHA) to Keranetics, LLC, a for-profit limited liability company. The contract was awarded on September 1, 2015 and has an ultimate completion date of January 31, 2021. The award is for the DHP SIBR SECOND PHASE II effort under SBIR Topic #OSD10-H03. The contract is a definitive contract with a cost-no-fee pricing type. Keranetics has prior experience as a federal grant prime...
The Department of the Army awarded a $167,499.96 firm-fixed-price Phase I Small Business Innovation Research (SBIR) program contract to Critical Innovations LLC, a limited liability company, for research and development efforts to develop treatments for dermal injuries caused by sulfur mustard. The contract has a total small business set-aside designation. Critical Innovations has previously received over $10 million in SBIR contracts from the Army, Defense Health Agency, and Air Force for...
This is a U.S. Army SBIR (Small Business Innovation Research) Phase II contract awarded to Silk Technologies, Ltd., a for-profit manufacturer, in the amount of $1,536,825.77. The contract was set aside for small businesses and was awarded by the Department of the Army Medical Command. The contract is for STTR (Small Business Technology Transfer) Phase III research, which typically involves the commercialization of technologies developed under previous SBIR/STTR phases. The work will be performed...
This is a firm fixed-price Definitive Contract awarded by the Department of the Army Medical Command to Critical Innovations LLC, a small business, under the Small Business Innovation Research (SBIR) program. The contract, valued at $1,100,000.00, is for the development of a "Nanostasis Intravenous Agent for Traumatic Hemorrhage Control" as part of a Phase II SBIR effort. Critical Innovations LLC is an ISO certified, DCAA compliant medical research and development company that has been...
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to Kerberos International, Inc., a self-certified small disadvantaged and women-owned small business. The $972,654.73 firm fixed-price contract will support Kerberos' STTR Phase II research and development efforts. Kerberos has extensive experience providing protective security officer services to federal agencies like the Department of Homeland...
This is a $150,000.00 Firm Fixed Price contract awarded by the Department of the Army Medical Command to Critical Innovations LLC, a small business limited liability company, under the Small Business Innovation Research (SBIR) program. The contract is for Phase I research and development of a "Nanostasis Intravenous Agent for Traumatic Hemorrhage Control". Critical Innovations is an ISO certified and DCAA compliant medical research and development company that has been awarded over $10...
The Department of the Army Medical Command awarded a $999,742.97 Small Business Innovation Research (SBIR) Phase II contract to Gama Therapeutics LLC, a for-profit organization, for the development of a "Miniature, Point-of-Care Device for Establishing Sterile Connections in Combat Environments." The contract was awarded on December 8, 2017, with a completion date of October 7, 2020. This fixed-price level of effort contract was awarded under the SBIR program, which provides funding to...